PISTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 11.710
AS - Asia 8.381
EU - Europa 6.100
SA - Sud America 1.686
Continente sconosciuto - Info sul continente non disponibili 679
AF - Africa 553
OC - Oceania 50
Totale 29.159
Nazione #
US - Stati Uniti d'America 11.359
IT - Italia 3.002
SG - Singapore 2.709
CN - Cina 1.630
HK - Hong Kong 1.560
BR - Brasile 1.367
VN - Vietnam 955
SE - Svezia 569
DE - Germania 428
FR - Francia 357
BG - Bulgaria 345
IN - India 332
GB - Regno Unito 317
RU - Federazione Russa 223
CI - Costa d'Avorio 219
FI - Finlandia 211
TR - Turchia 209
JP - Giappone 198
NL - Olanda 189
CA - Canada 175
AT - Austria 116
BD - Bangladesh 110
AR - Argentina 109
KR - Corea 100
ID - Indonesia 85
IQ - Iraq 78
MX - Messico 64
ZA - Sudafrica 61
PL - Polonia 49
UA - Ucraina 49
EC - Ecuador 47
PK - Pakistan 47
SA - Arabia Saudita 46
CO - Colombia 43
AU - Australia 41
VE - Venezuela 41
SN - Senegal 40
CH - Svizzera 39
MA - Marocco 37
NG - Nigeria 37
PH - Filippine 36
TN - Tunisia 35
ES - Italia 33
UZ - Uzbekistan 32
MY - Malesia 28
IE - Irlanda 27
AE - Emirati Arabi Uniti 26
EG - Egitto 26
TH - Thailandia 23
KE - Kenya 22
TT - Trinidad e Tobago 21
PY - Paraguay 19
JM - Giamaica 18
JO - Giordania 18
BE - Belgio 17
IL - Israele 17
IR - Iran 17
PE - Perù 17
UY - Uruguay 17
NP - Nepal 16
PT - Portogallo 16
CL - Cile 15
DZ - Algeria 14
KZ - Kazakistan 14
CZ - Repubblica Ceca 13
ET - Etiopia 13
BJ - Benin 12
CR - Costa Rica 12
GR - Grecia 12
DK - Danimarca 11
HU - Ungheria 11
LT - Lituania 11
RO - Romania 11
TW - Taiwan 11
AZ - Azerbaigian 9
DO - Repubblica Dominicana 9
BB - Barbados 8
HN - Honduras 8
LB - Libano 8
OM - Oman 8
AL - Albania 7
BH - Bahrain 7
BO - Bolivia 7
KH - Cambogia 7
NZ - Nuova Zelanda 7
SV - El Salvador 7
AM - Armenia 6
GT - Guatemala 6
LK - Sri Lanka 6
KW - Kuwait 5
LV - Lettonia 5
NO - Norvegia 5
TZ - Tanzania 5
CY - Cipro 4
LI - Liechtenstein 4
PA - Panama 4
PS - Palestinian Territory 4
RW - Ruanda 4
SY - Repubblica araba siriana 4
AG - Antigua e Barbuda 3
Totale 28.391
Città #
Ashburn 1.562
Hong Kong 1.529
Singapore 1.431
Dallas 854
San Jose 809
Santa Clara 622
Shanghai 493
Fairfield 479
Woodbridge 412
New York 396
Chandler 373
Sofia 342
Boardman 331
Florence 314
Beijing 302
Houston 299
Ho Chi Minh City 282
Milan 282
Ann Arbor 258
Princeton 248
Seattle 244
Pisa 235
Los Angeles 234
Wilmington 230
Hanoi 223
Abidjan 218
Lawrence 213
Lauterbourg 202
Tokyo 184
Cambridge 177
Munich 158
Rome 157
Medford 151
Hefei 134
Council Bluffs 133
Istanbul 127
Frankfurt am Main 112
Redondo Beach 104
São Paulo 99
Vienna 90
Buffalo 88
Seoul 85
Helsinki 78
London 74
San Diego 73
Ogden 67
Ottawa 65
Genoa 64
Chicago 62
Orem 55
Des Moines 54
Atlanta 52
Turku 52
Nanjing 51
Serra 46
Bologna 44
Belo Horizonte 41
Dakar 40
Naples 40
Rio de Janeiro 40
Warsaw 39
Turin 38
Da Nang 37
Lucca 37
Nuremberg 36
Pune 36
Livorno 34
Bremen 33
Brooklyn 31
Denver 31
San Francisco 31
Amsterdam 30
Baghdad 30
Haiphong 30
Jacksonville 30
Dong Ket 29
Düsseldorf 29
Johannesburg 29
Phoenix 29
Dearborn 28
Lancaster 28
Redwood City 27
Tashkent 27
Brasília 25
Montreal 25
Palermo 25
Cascina 24
Dublin 24
Jakarta 24
Mumbai 24
Bari 23
Chennai 23
Dhaka 23
Izmir 23
Tunis 23
Fuzhou 21
Guangzhou 20
Nairobi 20
Baltimore 19
Bengaluru 19
Totale 17.328
Nome #
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults 830
Diminishing benefits of urban living for children and adolescents' growth and development 360
Cessazione del fumo di sigarette di tabacco in individui resistenti alle terapie tradizionali; uno studio pilota di intervento mindfulness-based 329
Integrated environmental and clinical surveillance for the prevention of acute respiratory infections in closed settings and vulnerable communities: school, prison and nursing home (Stell-ARI Project) 268
Coagulation and fibrinolytic system impairment in insulin-dependent diabetes mellitus 266
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences? 264
Usefulness of a compendium of respiratory standard questionnaires for adults (CORSQ) 246
Percorso di follow-up clinico, funzionale e radiologico dei pazienti dimessi con diagnosi di COVID-19 dall’Azienda Ospedaliero-Universitaria Pisana (AOUP) - Metodologia e arruolamento preliminare 238
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 230
Epidemiologia ed effetti sulla salute del fumo di tabacco 229
Reduction of risk of dying from tobacco-related diseases after quitting smoking in Italy 229
Investigating Promising Point-of-Care Diagnostics in Pleural Effusion: Assessment of Bedside Glucometer Accuracy for Pleural Fluid Glucose Versus Standard Laboratory and Blood Gas Analyser Methods 220
Standardized Clinical, Functional, and Radiological Pulmonary Follow-Up in Patients Discharged with Diagnosis of COVID-19 From an Italian Hospital - Preliminary Data 218
Integrated environmental and clinical surveillance of viral acute respiratory infections in close communities: opportunities and challenges 210
Appendix 3: Compendium of respiratory standard questionnaires for adults (CORSQ) 209
Thoracic Ultrasound for Pre-Procedural Dynamic Assessment of Non-Expandable Lung: A Non-Invasive, Real-Time and Multifaceted Diagnostic Tool 200
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 198
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 195
Impact of long-term exposure to cigarette smoking on skin microvascular function 194
Screen-detected multiple primary lung cancers in the ITALUNG trial 193
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 186
Epidemiologia della broncopneumopatia cronico-ostruttiva: fattori di rischio ambientali ed occupazionali [Epidemiology of the chronic obstructive pulmonary disease: Environmental and occupational risk factors] 182
Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive 181
Basi fisiopatologiche, diagnosi e trattamento del tabagismo 181
Inclusion of peak expiratory flow for selection of the 'best' forced vital capacity manoeuvre 181
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants 181
Fattori individuali e ambientali di rischio respiratorio in soggetti vulnerabili che vivono in comunità chiuse (RSA e carcere): dati preliminari dello studio StellARI 180
L'epidemiologia della broncopneumopatia cronica ostruttiva 175
Respiratory symptoms/diseases prevalence is still increasing: A 25-yr population study 173
Integrated environmental and clinical surveillance for the prevention of acute respiratory infections (ARIs) in indoor environments and vulnerable communities (Stell-ARI): Protocol 166
Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice 166
I centri antifumo in Italia e il progetto 6elle 165
Definition, epidemiology and natural history of COPD 164
RItA: The Italian severe/uncontrolled asthma registry 164
Smooth reference equations for slow vital capacity and flow-volume curve indexes 161
ARDS da prolasso mitralico acuto in assuntore di cocaina 160
Family history for chronic lung diseases and epidemiological determinants of COPD in three European countries 159
L’attività dei Centri Antifumo italiani tra problematiche e aree da potenziare: i risultati di un’indagine svolta attraverso un questionario on-line 159
Utilità dei complessi Trombina-Antitrombina nella diagnosi di embolia polmonare 157
Reference equations for spirometry from a general population sample in central Italy 155
Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis 152
Life gain in Italian smokers who quit 152
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients 150
Fumo di sigaretta in gravidanza: studio osservazionale prospettico in tre città della Toscana [Cigarette smoking in pregnancy: observational prospective study in three towns of Tuscany Region (Central Italy)] 148
COPD management according to old and new GOLD guidelines: An observational study with Italian general practitioners 147
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors 146
18-yr cumulative incidence of respiratory/allergic symptoms/diseases and risk factors in the Pisa epidemiological study 146
Valori di riferimento e standardizzazione dei referti 144
Quantitative CT Texture Analysis of COVID-19 Hospitalized Patients during 3–24-Month Follow-Up and Correlation with Functional Parameters 144
Pulmonary phenotypes and COVID-19 evolution patterns during the first year of the pandemic 144
Smoking Cessation in the ITALUNG Lung Cancer Screening: what does “teachable moment” mean? 144
Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples 143
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis 142
Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation 142
Depressive, anxious, withdrawal symptoms, and craving as possible predictors of abstinence maintenance in smokers attending a 12-week quitting program 140
null 138
Percentiles of Inspiratory Capacity in Healthy Nonsmokers: A Pilot Study 138
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 137
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 137
Multy-symptom asthma (msa) as indication of healthcare utilization burden (hub) in a cohort of Italian young asthmatic subjects 136
Urban residence is associated with bronchial hyper-responsiveness in Italian general population samples 136
Long-term lung ultrasound follow-up in patients after COVID-19 pneumonia hospitalization: A prospective comparative study with chest computed tomography 133
Respiratory symptoms/diseases and lifetime cumulative exposure to environmental tobacco smoke (ETS) in never smoker Italian women (SEASD Study) 132
Weight gain after smoking cessation 132
Prescriptive appropriateness using the new GOLD guidelines in the COMODHES study with Italian general practitioners 132
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment 132
Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study 130
Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch 130
Short term longitudinal evaluation of smoking-related emphysema: analisys from Italung-CT Study 129
Changes in obesity status and lung function decline in a general population sample 129
Integrating the care of the complex COPD patient 128
Nicotine Metabolite Ratio in Smokers: A Real World Experience 125
Abitudini al fumo e sintomi/diagnosi di BPCO in un campione di popolazione generale monitorato per 25 anni 124
Esperienza di un intervento condotto da fisioterapista respiratorio e infermiere per favorire la cessazione del fumo in pazienti degenti in un reparto di Pneumologia 124
Sorveglianza clinica e ambientale integrata per virus respiratori in RSA (Residenza sanitaria assistenziale): criticità e opportunità 123
Overlap delle malattie respiratorie: fenotipi eosinofilici in un campione italiano di popolazione generale 123
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 123
Variation of obstructive severity in an Italian general population sample surveyed 18 years apart 122
Characteristics of smokers according to their Nicotine Metabolite Ratio, preliminary results from a real-life experience 122
Eroina e asma bronchiale 121
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects 120
null 120
Electronic cigarette use among Italian smokers: patterns, settings, and adverse events 120
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial 120
Eosinophilic phenotypes of overlapping respiratory diseases in an Italian general population sample 118
Relazione tra profilo metabolico della nicotina e caratteristiche demografiche, cliniche e di abitudine al fumo. Risultati preliminari nella vita reale 117
Moderate-severe coronary calcification predicts long-term cardiovascular death in CT lung cancer screening: The ITALUNG trial 117
DEVELOPMENT AND IMPLEMENTATION OF A DATABASE FOR RETROSPECTIVE ANALYSIS OF IMMUNE CHECKPOINT INHIBITOR-RELATED PNEUMONITIS IN A COHORT OF LUNG CANCER PATIENTS 114
Mortalità per malattie respiratorie in Italia (1990-2010). Parte II: Tassi standardizzati, confronto con l’Europa e conclusioni. 114
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 114
Lung function in a group of smokers or ex smokers enrolled in a randomized controlled trial (RCT) with low-dose computer tomography (CT) for lung cancer screening (ITALUNG-CT study) 113
Comparison of characteristics between populations belonging to two different lung cancer screening (LCS) protocol sheld in Pisa with low-dose chest CT (LDCT): Italung 1 (ITL1) versus Italung 2 (ITL2) 112
Mortalità per malattie respiratorie in Italia (1990-2010). Parte I: Metodi e tassi grezzi nazionali e per regione 111
Characteristics of long-COVID among older adults: a cross-sectional study 109
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT 109
Volume di prestazioni erogate dai Centri antifuno italiani e loro caratetristiche predittive di successo nei tentativi per smettere effettuati dai fumatori afferenti 109
PLASMA/SALIVA AND GENOTYPIC/PHENOTYPIC DIFFERENCES OF NICOTINE METABOLITE RATIO 109
Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition 108
Quantitative HRCT as a surrogate outcome measure for nintedanib treatment in systemic sclerosis-interstitial lung disease and idiopathic pulmonary fibrosis 107
Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects 107
Totale 16.410
Categoria #
all - tutte 98.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.989 0 70 27 59 339 322 224 75 128 50 169 526
2022/20232.088 346 180 160 133 166 215 40 117 475 21 150 85
2023/20242.227 134 151 204 120 281 478 122 170 69 75 133 290
2024/20258.258 223 335 174 402 561 536 732 444 958 1.186 807 1.900
2025/202610.191 417 1.197 1.341 1.322 935 777 1.389 525 631 908 427 322
2026/20271.109 872 237 0 0 0 0 0 0 0 0 0 0
Totale 29.159